Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $1.0 million.

  • Stemtech's Operating Expenses fell 2530.86% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 3727.1%. This contributed to the annual value of $6.1 million for FY2024, which is 2493.32% down from last year.
  • As of Q3 2025, Stemtech's Operating Expenses stood at $1.0 million, which was down 2530.86% from $853004.0 recorded in Q2 2025.
  • Stemtech's 5-year Operating Expenses high stood at $4.2 million for Q3 2022, and its period low was $853004.0 during Q2 2025.
  • Its 5-year average for Operating Expenses is $1.7 million, with a median of $1.6 million in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 18004.93% in 2022, then tumbled by 6266.25% in 2023.
  • Stemtech's Operating Expenses (Quarter) stood at $2.7 million in 2021, then plummeted by 55.91% to $1.2 million in 2022, then soared by 116.92% to $2.6 million in 2023, then tumbled by 60.61% to $1.0 million in 2024, then grew by 0.97% to $1.0 million in 2025.
  • Its Operating Expenses was $1.0 million in Q3 2025, compared to $853004.0 in Q2 2025 and $1.9 million in Q1 2025.